Defensive trim 25-35% of JPM to 50-75% benchmark weight on stacked caution signals; preserve core for franchise quality
Underweight justified by stacked caution signals (MACD bearish cross with histogram -0.83 and widening, sub-10 EMA and sub-VWMA positioning, RSI rollover 68→52, Bollinger squeeze $349-363 with bearish momentum lean) and clustered sentiment indicators (ABR overly-optimistic, StockStory sell, Zacks caution, ERP at 2002 lows per JPM strategists). Trim magnitude 25-35% (not 50%) preserves franchise floor (17.8% ROE, $47B annualized capital returns, $310B TCE, $24.8B ACL, $33B annual buyback) while reducing concentration risk from 9/3 binding lesson. Full Sell avoided due to unmet 8/21 exit signal (50 SMA intact at $351.71) and 55% bullish breakout probability versus 15% bearish breakdown per technical report. Asymmetric payoff favors trim: 5-7% upside to $375 vs 13-22% downside to $280-310 on credit inflection.
| Position | Action |
|---|---|
| Current position | Trim 25-35% via hybrid trigger |
| Post-trim residual position | Maintain at 50-75% of benchmark weight |
| Add Zone 1: confirmed close $338-342 | Add 7-8% incrementally with bullish reversal candle, volume >7M, positive MACD histogram turn |
| Add Zone 2: confirmed close above $366 | Reassess toward neutral on volume >7M with MACD bullish re-cross |
| Break below $348 with volume expansion | Reassess toward full Underweight/Sell |
JPM's 47% YoY earnings growth, accelerating NII from hawkish Fed pivot, institutional-only positioning, and $47B annual capital return create an asymmetric risk/reward where inaction risks missing the next leg higher.
| Indicator | Value | Signal |
|---|---|---|
| close | $356.23 | neutral |
| 10_ema | $355.96 | neutral |
| 50_sma | $351.71 | bullish |
| 200_sma | $317.50 | bullish |
| macd | 0.98 | bearish |
| macd_signal | 1.82 | bearish |
| macd_histogram | -0.83 | bearish |
| rsi | 51.90 | neutral |
| boll_upper | $363.53 | neutral |
| boll_middle | $356.74 | neutral |
| boll_lower | $349.94 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: 3 trading sessions from now with no fill
Then: Execute 25-35% defensive trim
The macro tailwind for NII is accelerating, not plateauing — hawkish Fed is bullish for JPM
↩ rebuts: “Bear claim that 'NII has plateaued'”
EV: +4–5% on breakout to $370–$375; fundamental upside from NII re-acceleration not yet priced in · concedes: A P/E of 15x is 'reasonable, and arguably underpriced relative to the EPS revisions still to come' — acknowledging some premium is priced; Bear technical analyst assigned highest probability (55%) to bullish breakout — the call for HOLD is inconsistent with their own probability estimates
JPM is a great company at the wrong price — the risk/reward is negative at current levels due to inflated EPS, plateauing NII, building credit cycle risks, and bearish sentiment signals.
EV: -2.74% · concedes: ROE of 17.79% does justify some P/B premium above historical averages; JPM is fundamentally a strong, well-run institution — the argument is timing and valuation, not quality
→ vs aggressive: Challenges conservative/hold-forever crowd: argues they are missing that great businesses can be terrible trades at wrong prices, and that negative expected value at current levels demands action rather than passivity
→ vs neutral: Challenges 'hold and wait' recommendation: argues holding is the coward's trade when a franchise is at peak multiple with primary earnings driver flattening, and that disciplined risk management means trimming when risk-reward skews ugly
→ vs conservative: Challenges conservative credit cycle lag dismissal: notes probabilistic scenario analysis shows negative expected value of minus 2.74 percent, calling it a meaningful—not marginal—negative expectancy at current prices
→ vs aggressive: Challenges bull case requiring everything to go right: Fed hikes and signals more, curve steepens, credit holds, AI debt flows, trillion-dollar narrative continues—versus bear case needing only one thing wrong to trigger 10 to 15 percent drawdown
| atr | 5.92 | neutral |
| vwma | $356.20 | neutral |
Support: 349.94 · 351.71 | Resistance: 363.53 · 366.5
JPM is in a structurally bullish long-term regime (well above 200 SMA) but experiencing a neutral short-term consolidation phase. The 50 SMA at $351.71 has successfully held as support (tested on 2026-08-20 at $351.55), while the 10 EMA hugging the current price ($355.96 vs $356.23) signals indecision. MACD shows mild bearish momentum (histogram -0.83) but is narrowing, not reversing. Bollinger Bands are contracting into a squeeze, typically a precursor to directional expansion. VWMA declining from $359 to $356.20 confirms no strong volume-backed trend. ATR of $5.92 indicates controlled, low-volatility conditions favorable for tight position management. Key pivot at $356.74 with resistance at $363.53 (upper BB) and $366.50 (August peak), support at $351.71 (50 SMA) and $349.94 (lower BB). Final recommendation: HOLD — bullish structure intact, awaiting directional catalyst.
Market Cap
$946.93B
Beta
0.975
P/E (TTM)
15.27
Forward P/E
14.26
PEG Ratio
1.65
Price/Book
2.68
EPS (TTM)
$23.33
Forward EPS
$24.99
Dividend Yield
1.70%
TTM Revenue
$186.33B
TTM Net Income
$63.63B
Profit Margin
34.92%
Operating Margin
50.39%
ROE
17.79%
ROA
1.36%
Book Value/Share
$133.01
Total Assets
$5,015B
Total Equity
$374.6B
Tangible Book Value
$289.3B
Net Loans
$1,516B
Goodwill & Intangibles
$64.3B
Total Debt
$533.0B
Cash & Equivalents
$309.8B
Q2 2026 Revenue
$52.85B
Q2 2026 Net Income
$21.16B
Q2 2026 Diluted EPS
$7.70
Q2 2026 Net Interest Income
$25.51B
Q2 2026 Pretax Income
$27.52B
Annual Dividend
~$17B+
Annual Buybacks
~$30B+
Share Count Reduction YoY
-3.6%
Diluted Share Count Q2 2026
2.694B
Diluted Share Count Q2 2025
2.794B
52-Week High
$366.50
52-Week Low
$279.10
50-Day MA
$351.30
200-Day MA
$319.15
Q2 2026 Special Item
$4.39B
Effective Tax Rate Q2 2026
~23%
CET1 Ratio
~16%+
Treasury Stock Q2 2026
$178B
Net Debt Q2 2026
$223.1B
Salaries & Wages Q2 2026
$15.16B
Salaries & Wages Q2 2025
$13.71B
Net Long-Term Debt Issuance Q2 2026
$7.55B
Net Long-Term Debt Issuance Q1 2026
$17.96B
Strengths
Concerns
JPMorgan Chase remains the highest-quality large-cap bank franchise in the U.S., with industry-leading 17.8% ROE, accelerating Q2 2026 earnings (EPS $7.70, +47% YoY), and massive ~$47B annual capital return program. The stock trades near 52-week highs ($366.50) with a P/E of 15.27x and P/B of 2.68x, pricing in much of the optimism, while NII growth has begun to plateau quarter-over-quarter suggesting the rate benefit cycle may be peaking. The actionable recommendation is HOLD existing positions rather than initiating new longs near all-time highs, with a pullback to the 50-day MA (~$351) or 200-day MA (~$319) representing more attractive risk-adjusted entries ahead of Q3 2026 earnings in mid-October.
Macro: The dominant macro narrative is a hawkish Fed pivot: Polymarket pricing flipped from rate-cut expectations to rate-hike expectations with 82% odds of a hike by the September 16-17 FOMC meeting (up 32pp in one week), 90% odds of at least one hike in 2026, and the rate-cut narrative essentially dead (0% by Sept, 6% by Dec). August CPI was firm with sticky inflation persisting; gold rebounding toward $3,500 and 10Y Treasury near 5%. JPMorgan's own research baseline calls for a hold at the September meeting followed by a December hike, with 8 of 9 DM central banks tightening before year-end. Treasury Secretary Bessent's warning to bond vigilantes has failed to anchor yields. Recession odds remain low at 7%, supporting the soft-landing thesis.